白细胞介素-9促进脓毒症肠道屏障损伤:一项转化研究
该转化研究在脓毒症患者与对照中检测血清产IL-9的CD4+ T细胞百分比、IL-9和D-乳酸水平,并在脓毒症大鼠中检测血清与肠组织屏障功能标志物,且通过增高或干扰IL-9表达观察屏障损伤程度与生存率。结果显示脓毒症患者或大鼠的产IL-9的CD4+ T细胞百分比、IL-9和D-乳酸水平均显著高于对照;产IL-9的CD4+ T细胞与IL-9水平与D-乳酸水平正相关,对脓毒症患者28天死亡有较高预测价值;非存活者上述指标显著高于存活者。大鼠中IL-9升高D-乳酸表达、降低闭锁小带蛋白1表达,增高IL-9表达加重屏障损伤、干扰IL-9表达减轻屏障损伤,IL-9降低脓毒症大鼠14天生存率。作者认为IL-9与脓毒症肠黏膜屏障损伤及死亡密切相关,阻断IL-9有改善脓毒症屏障损伤的潜力。
要点
- 脓毒症患者血清产IL-9的CD4+ T细胞百分比、IL-9和D-乳酸水平显著高于对照。
- 产IL-9的CD4+ T细胞与IL-9水平同D-乳酸水平正相关,并对脓毒症患者28天死亡有较高预测价值。
- 脓毒症非存活者血清T细胞百分比、IL-9和D-乳酸水平显著高于存活者。
- 脓毒症大鼠中IL-9升高D-乳酸表达、降低闭锁小带蛋白1表达,增高IL-9加重屏障损伤、干扰IL-9减轻屏障损伤。
- IL-9降低脓毒症大鼠14天生存率,作者认为阻断IL-9有改善脓毒症屏障损伤的潜力。
适用人群与场景
- 脓毒症患者与对照(对照具体定义原文未写明)
- 脓毒症大鼠
研究设计与关键结果
- 研究类型:转化研究,包含脓毒症患者与对照的临床检测及脓毒症大鼠实验;于ClinicalTrials.gov注册(ID: NCT03791866,日期:2018年12月)。
- 脓毒症患者或大鼠的血清产IL-9的CD4+ T细胞百分比、IL-9和D-乳酸水平显著高于对照。
- 产IL-9的CD4+ T细胞与IL-9水平同D-乳酸水平正相关,并对脓毒症患者28天死亡有较高预测价值。
- 脓毒症非存活者血清T细胞百分比、IL-9和D-乳酸水平显著高于存活者。
- 脓毒症大鼠中IL-9升高D-乳酸表达、降低闭锁小带蛋白1表达。
- 增高IL-9表达加重屏障损伤,干扰IL-9表达减轻屏障损伤。
- IL-9降低脓毒症大鼠14天生存率。
证据类型、等级与局限
- 证据类型:转化研究(临床样本检测联合动物实验)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为IL-9与脓毒症肠黏膜屏障损伤及死亡密切相关,阻断IL-9有改善脓毒症屏障损伤的潜力。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. Intestinal mucosal barrier injury is one of the important manifestations of sepsis. Interleukin-9 (IL-9) and IL-9-producing CD4(+) T cells were emerging pro-inflammatory mediators with development of intestinal injury. However, it is unclear whether IL-9 is related to the intestinal barrier injury of sepsis.
METHODS: To investigate the roles of IL-9-producing CD4(+) T cells and IL-9 in the process of barrier injury in sepsis, serum IL-9-producing CD4(+) T cell percentages, IL-9, and D-lactate levels were measured in septic patients and controls. The markers of barrier function in serum and intestinal tissue were also collected in septic rats. Moreover, the barrier injury degree and survival rate of septic rats were also investigated after increasing or interfering with IL-9 expression.
RESULTS: The serum IL-9-producing CD4(+) T cell percentages, IL-9, and D-lactate levels were significantly higher in septic patients or rats than those in controls. IL-9-producing CD4(+) T cells and IL-9 levels were positively correlated with D-lactate levels and had a high predictive value of 28-day mortality in septic patients. The non-survivors had significantly higher serum T cell percentages, IL-9, and D-lactate levels compared with survivors. In septic rats, IL-9 increased the expression levels of D-lactate, whereas that decreased the expression levels of zonula occludens 1. Moreover, the barrier injury was aggravated or alleviated by increasing or interfering with IL-9 expression, respectively. Survival rate analysis also showed that IL-9 decreased the 14-day survival rate of septic rats.
CONCLUSION: IL-9 is closely related to intestinal mucosal barrier injury and mortality in sepsis. IL-9 blockade has the potential to improve the barrier injury in sepsis.
TRIAL REGISTRATION: The study was registered at ClinicalTrials.gov (ID: NCT03791866, Date: December 2018).
参考来源
- Sun JK, Zhou J, Sun XP, et al. Interleukin-9 promotes intestinal barrier injury of sepsis: a translational research. J Intensive Care. 2021. PMID: 33941281. doi:10.1186/s40560-021-00550-y
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。